• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION LONGFORD ARCHITECT TOTAL B-HCG

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION LONGFORD ARCHITECT TOTAL B-HCG Back to Search Results
Model Number 7K78-30
Device Problem False Positive Result (1227)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/12/2020
Event Type  malfunction  
Manufacturer Narrative
Device evaluation is in process.A follow-up will be submitted once the evaluation is complete.
 
Event Description
The customer stated that a false positive architect total bhcg result of 494.04 miu/ml was generated for a patient sample that retested negative at <1.2 miu/ml.The patient is a (b)(6) year old female without childbearing potential.No adverse impact to patient management was reported.
 
Manufacturer Narrative
The complaint investigation for a false positive result for one patient when tested with the architect total b-hcg assay included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labelling review, device history record review and field data review for the complaint lot.Trending review determined no adverse trend for the product.Device history record review did not identify any non-conformances or deviations with the likely cause lot.In house testing of panels which mimic patient samples was completed using retained samples of the complaint lot.All specifications were met indicating that the lot is performing acceptably.World wide data from abbottlink was reviewed and determined that patient median result for the lot is comparable with other lots in the field.Based on our investigation, we have determined that there is no general issue with the architect total b-hcg reagent lot identified in the complaint.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT TOTAL B-HCG
Type of Device
B-HCG
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION LONGFORD
lisnamuck
co. longford
longford NA
EI  NA
MDR Report Key10186893
MDR Text Key226764803
Report Number3005094123-2020-00133
Device Sequence Number1
Product Code DHA
UDI-Device Identifier00380740014971
UDI-Public00380740014971
Combination Product (y/n)N
PMA/PMN Number
K983424
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 08/21/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/23/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/20/2020
Device Model Number7K78-30
Device Catalogue Number07K78-30
Device Lot Number04405UI00
Was Device Available for Evaluation? No
Date Manufacturer Received08/20/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR ANALYZER, LIST 03M74-02; ARCHITECT I2000SR ANALYZER, LIST 03M74-02,; SERIAL NUMBER (B)(4); SERIAL NUMBER (B)(4)
Patient Age50 YR
-
-